Ondine Biomedical Inc. (AIM:OBI)
United Kingdom flag United Kingdom · Delayed Price · Currency is GBP · Price in GBX
9.30
-0.10 (-1.06%)
Nov 4, 2026, 3:24 PM GMT

Ondine Biomedical Ratios and Metrics

Millions GBP. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
5239362040108
Market Cap Growth
-7.85%9.33%79.20%-50.26%-63.06%-
Enterprise Value
5036351827109
Last Close Price
0.090.090.090.090.200.56

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
34.1727.1131.2627.74101.9672.03
PB Ratio
-20.589.3116.015.596.24
P/TBV Ratio
-20.589.3116.015.596.24

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
32.4225.2430.8224.9069.7472.76

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-0.090.120.020.260.120.02
Net Debt / Equity Ratio
1.58-2.91-1.40-1.17-1.01-1.00
Net Debt / EBITDA Ratio
0.150.340.500.170.631.72
Net Debt / FCF Ratio
0.190.420.620.180.712.35
Asset Turnover
0.330.200.220.110.030.14
Inventory Turnover
0.660.670.620.420.301.80
Quick Ratio
0.471.021.730.953.417.81
Current Ratio
0.651.232.051.363.878.54
Return on Equity (ROE)
--569.72%-426.20%-209.95%-93.81%-
Return on Assets (ROA)
-236.33%-137.70%-130.98%-82.98%-46.25%-59.55%
Return on Capital Employed (ROCE)
1042.00%-835.70%-282.70%-659.80%-148.20%-58.00%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-36.87%-41.15%-29.82%-43.18%-29.78%-27.07%
FCF Yield
-27.66%-33.41%-24.20%-41.44%-25.60%-6.82%
Buyback Yield / Dilution
-37.62%-69.37%-39.31%-1.30%-144.34%-12.69%